Skip to content
Research Article Open access CC BY 4.0

Currently Observed Trend in the Resistance of Malaria to Artemisinin Based Combination Therapy in Nigeria – A Report of 5 Cases

Gonen S. Wundermann, Agbonmeire Awele Osiki

International Journal of TROPICAL DISEASE & Health · pp. 1–5 · Published 3 Feb 2017

10.9734/IJTDH/2017/30914

Abstract

Malaria is a life threatening disease caused by parasites transmitted through the bite of an infected female mosquito. About 3.2 million (about half of the world’s population) are at risk of malaria; it affects all age group from young to old. Between 2002 – 2015, Sub-Saharan Africa was home to 88% of malaria cases and 90% of malaria deaths most of which were under-five years old.  Plasmodium falciparum – transmitted by female Anopleles mosquito (one of the five parasites that cause malaria in humans) is the most prevalent malaria parasite in the African continent and is responsible for most malaria-related deaths globally [1]. Artemisinin-based combination therapy (ACT) resistance is rare in Sub-Saharan Africa. The World Health Organization (WHO) identifies monitoring and surveillance using day – 3 parasitaemia post treatment as the standard test for identifying suspected artemisinin resistance [2]. Early treatment failure due to possible ACT resistant Plasmodium falciparum has been identified in 5 cases across different age group, race, sex and gender. All cases managed showed significant clinical and parasitological responses to further treatment with combined Artesunate (intravenous) and Arthemeter (intramuscular), Arthemeter only (IM) or Artesunate tablets. This study seeks to emphasize the need for a re-evaluation of the malaria treatment protocol and to throw more light on the increasing resistance of Plasmodium falciparum to the commonly used Artemisinin – based combination therapy agents in Nigeria.

Artemisinin based combination therapy malaria artesunate resistance arthemether Nigeria

Cited by 8

Surveillance of Antimalarial Drug-Resistance Genes in Imported Plasmodium falciparum Isolates From Nigeria in Henan, China, 2012–2019

Dongyang Zhao, Hongwei Zhang, Penghui Ji · Frontiers in Cellular and Infection Microbiology · 2021

In vitro antiplasmodial activity, cytotoxicity, antioxidant action and GC-FID analysis of Allanblackia floribunda Oliv

Francis Irabor, Osamudiamen Ebohon, Nekpen Erhunse · SN Applied Sciences · 2021

Status of Artemisinin Resistance in Malaria Parasite Plasmodium falciparum from Molecular Analyses of the Kelch13 Gene in Southwestern Nigeria

Mary Aigbiremo Oboh, Daouda Ndiaye, Hiasindh Ashmi Antony · BioMed Research International · 2018

Molecular profiling of the artemisinin resistance Kelch 13 gene in Plasmodium falciparum from Nigeria

Fehintola V. Ajogbasile, Paul E. Oluniyi, Adeyemi T. Kayode · PLOS ONE · 2022

Therapeutic failure after regimen with artemether-lumefantrine combination therapy: a report of three cases in Benin City, Nigeria

Osamudiamen Ebohon, Francis Irabor, Linda Osahon Ebohon · Revista da Sociedade Brasileira de Medicina Tropical · 2019

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

8

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.